1. Home
  2. PDI vs CRL Comparison

PDI vs CRL Comparison

Compare PDI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Fund

PDI

PIMCO Dynamic Income Fund

HOLD

Current Price

$18.08

Market Cap

7.7B

Sector

Finance

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$184.48

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDI
CRL
Founded
2012
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.0B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
PDI
CRL
Price
$18.08
$184.48
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
$190.15
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
01-01-0001
11-05-2025
Dividend Yield
13.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,023,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.45
$91.86
52 Week High
$19.60
$202.72

Technical Indicators

Market Signals
Indicator
PDI
CRL
Relative Strength Index (RSI) 46.70 62.90
Support Level $17.32 $172.95
Resistance Level $18.12 $180.95
Average True Range (ATR) 0.17 5.70
MACD 0.08 1.54
Stochastic Oscillator 73.08 95.04

Price Performance

Historical Comparison
PDI
CRL

About PDI PIMCO Dynamic Income Fund

PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: